|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
|
|---|---|---|---|---|---|
| ASSETS | |||||
| Current Assets | |||||
| Cash and cash equivalents | |||||
| Accounts receivable, net | |||||
| Inventory | |||||
| Prepaid expenses and other current assets | |||||
| Total current assets | |||||
| Property and equipment, net | |||||
| Operating lease right-of-use assets | |||||
| Other long-term assets | |||||
| TOTAL ASSETS | |||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||
| Current Liabilities | |||||
| Accounts payable | |||||
| Accrued expenses and other current liabilities | |||||
| Deferred revenue | |||||
| Note payable, current | |||||
| Operating lease liabilities - current | |||||
| Total current liabilities | |||||
| Operating lease liabilities – long-term | |||||
| Total liabilities | |||||
| Convertible preferred stock | |||||
| Series A | |||||
| Series B | |||||
| Series C | |||||
| Series C-1 | |||||
| Series D | |||||
| Series D-1 | |||||
| Series D-2 | |||||
| Series E | |||||
| Series F-1 | |||||
| Series F-2 | |||||
| Series G | |||||
| Series G-1 | |||||
| Series H | |||||
| Total convertible preferred stock | |||||
| Stockholders’ Equity | |||||
| Preferred stock, $0.001 par value: 10,000,000 shares authorized and none issued and outstanding as of June 30, 2026; 10,000,000 shares authorized and none issued and outstanding as of December 31, 2025 | |||||
| Common stock, $0.001 par value: 300,000,000 shares authorized as of June 30, 2026; 50,032,148 and 46,865,051 issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | |||||
| Additional paid-in capital | |||||
| Accumulated deficit | |||||
| Total stockholders’ equity | |||||
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY |
Loading...
